Epstein Secrets

From: Ike Groff Subject: Early Tour 4.17.14 Date: Thu, 17 Apr 2

timates, sticks to outlook (trading -3.3%) • Atos Q1 revenues -1.8% versus estimate -1.4%, booking light, confirms 2104 outlook (trading -1.4%) • Publicis O1 organic growth beats estimates, reiterates 2014 growth target (trading +2.1%) • Akzo Nobel profit stagnates on revamp costs and fx, O1 sales mis

From: Ike Groff Subject: Early Tour 11.12.12 Date: Mon, 12 Nov 2

better, sales on par with 2011 (trading -0.42%) • Redrow IMS looks ok, continues to make progress in tough & stable environment (trading -1.5%) • Publicis (unusually) reports very strong October organic growth, no Nov/Dec comment (trading +2.8%) • JC Decaux: Le Figaro reports that the digital business

From: Ike Groff Subject: Early Tour 11.13.12 Date: Tue, 13 Nov 2

s set out within strategic plan (trading -2.5%) • Swiss Life O3 sales slightly better driven by France, 9 month premiums inline (trading -1.3%) • Publicis receives approval from AFM for LBI bid of Eur2.85 per share (trading -0.54%) • Pirelli quarterly revs inline, EBIT and net light, cutting 2012 sale